1. Home
  2. MATH vs ELTX Comparison

MATH vs ELTX Comparison

Compare MATH & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

HOLD

Current Price

$2.66

Market Cap

145.4M

Sector

Finance

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$9.01

Market Cap

158.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATH
ELTX
Founded
2015
2011
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.4M
158.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MATH
ELTX
Price
$2.66
$9.01
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
115.0K
105.8K
Earning Date
12-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.41
N/A
Revenue
$44,567,257.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.63
N/A
Revenue Growth
165.86
N/A
52 Week Low
$0.88
$4.60
52 Week High
$4.17
$12.62

Technical Indicators

Market Signals
Indicator
MATH
ELTX
Relative Strength Index (RSI) 41.92 47.43
Support Level $2.75 $7.87
Resistance Level $3.03 $9.55
Average True Range (ATR) 0.22 0.49
MACD 0.00 0.11
Stochastic Oscillator 30.43 65.48

Price Performance

Historical Comparison
MATH
ELTX

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: